IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Performance
Performance Report
Remus Pharmaceuticals IPO listing price is ₹ 1711.00, issue price is ₹ 1229.00, and currently trading at ₹ 1927.35 as on June 11, 2025. Remus Pharmaceuticals IPO performance is show below with latest CAGR.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Remus Pharmaceuticals IPO is a Book Building listing on NSE EMERGE exchange. The company is based in Ahmedabad and caters to Pharmaceutical sector. Beeline Capital Advisors is the merchant banker of Remus Pharmaceuticals IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 10th March 2023.
Remus Pharmaceuticals IPO offer price is ₹ 1229.00 and got listed at ₹ 1711.00. Read Remus Pharmaceuticals IPO details mentioned above.The IPO of Remus Pharmaceuticals Limited was listed on 29th May 2023. As of today, Remus Pharmaceuticals IPO is trading at ₹ 1927.35, compared to the previous day’s close of ₹ 1958.45. Read the report above for detailed IPO performance.
The issue price of Remus Pharmaceuticals IPO was ₹ 1229.00 per equity share.
Remus Pharmaceuticals IPO was listed at ₹1711.00 on the stock exchange on 29th May 2023. The listing price is the price at which the shares started trading on the stock exchange after the IPO was completed.
As of June 11, 2025, the current market price of Remus Pharmaceuticals IPO is ₹ 1927.35.
The 52-week high for Remus Pharmaceuticals IPO is [●], while the 52-week low is [●]. These figures reflect the stock’s highest and lowest trading prices in the past one year from the current date.
The Remus Pharmaceuticals IPO listed at ₹ 1711.00 against the issue price of ₹ 1229.00 per equity share, showing a listing day gain/loss of 482 (39.22%) , calculated by comparing the listing price to the issue price on the first day of trading.
The Remus Pharmaceuticals IPO stock moved from its listing price of ₹ 1711.00 to the current price of ₹1927.35 per equity share, reflecting a change of 12.64% per share, calculated by subtracting the listing price from the current market price (CMP) as of today.
Based on Remus Pharmaceuticals IPO issue date of 29th May 2023 and CMP of ₹1927.35, the estimated CAGR is approximately 24.52%.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Face
Value :
₹ 10
Issue
Price :
₹ 1229.00
Listing Price :
₹ 1711.00
Previous Day Closing
₹ 1958.45
Remus Pharmaceuticals IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Remus Pharmaceuticals Financial Review Page
Merchant Banker(s) of Remus Pharmaceuticals IPO: Beeline Capital Advisors Private Limited
Remus Pharmaceuticals IPO subscription was 57.21 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Remus Pharmaceuticals IPO listed at a listing price of 1711.00 against the offer price of 1229.00.
The current market price of Remus Pharmaceuticals is 1927.35.
Why Us?
